V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20113342 | 20134066 | 1.79 | 62.9 | Palliative (P) | 2016-04-26 | 2016-04-29 | CETUXIMAB + IRINOTECAN | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101193866 |
| 20113405 | 20134067 | 1.8 | 44.8 | Palliative (P) | null | 2017-08-05 | ECarboX | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100152068 |
| 20113533 | 20134068 | 1.73 | 80 | null | 2019-12-17 | 2019-12-20 | CABOZANTINIB | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100225808 |
| 20113562 | 20134069 | 1.75 | 71 | Palliative (P) | 2017-02-05 | 2017-03-21 | Venetoclax | 02 | N | CETUXIMAB + IRINOTECAN | 100907376 |
| 20114008 | 20134070 | 1.81 | 89 | 03 | 2021-05-11 | 2021-05-31 | CISPLATIN + FLUOROURACIL + RT | 02 | null | LOMUSTINE | 101477786 |
| 20114120 | 20134071 | 1.8 | 57.9 | null | 2018-01-16 | 2018-08-24 | ECF | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101009875 |
| 20114406 | 20134072 | 1.58 | 73 | 03 | 2017-12-20 | 2017-12-27 | FLUOROURACIL + OXALIPLATIN + Trastuzumab | 1 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101599390 |
| 20114409 | 20134073 | null | null | Palliative (P) | 2019-04-29 | 2019-05-13 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | CARBOPLATIN + VINORELBINE | 100449958 |
| 20114769 | 20134075 | 1.75 | 61.8 | Palliative (P) | 2019-10-03 | 2019-10-24 | Gemcitabine + Paclitaxel | N | N | CYCLOPHOSPHAMIDE | 101262332 |
| 20115021 | 20134077 | 1.68 | 76 | Palliative (P) | 2022-03-14 | 2022-03-24 | CAM-PLEX Trial | 02 | N | EOF | 100795971 |
| 20115264 | 20134079 | 1.71 | 66.5 | Curative (C) | 2018-07-01 | 2018-07-13 | Gemcitabine+Paclitaxel (Neo-tAnGo) | N | null | CAPITAL TRIAL | 100772298 |
| 20115341 | 20134080 | 1.74 | 61 | null | 2019-11-28 | 2020-01-22 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | COSMIC TRIAL | 101484039 |
| 20115483 | 20134081 | 1.56 | 61.4 | Curative (C) | 2018-08-27 | 2018-09-02 | Bevacizumab + Irinotecan + MdG | 02 | null | RITUXIMAB | 100547672 |
| 20115510 | 20134082 | 1.55 | 65 | Palliative (P) | 2017-04-18 | 2017-05-15 | Hepatoblastoma Relapse VI | N | N | OXALIPLATIN + MDG + PANITUMUMAB | 101634179 |
| 20115640 | 20134084 | 1.69 | 55 | Palliative (P) | 2020-09-22 | 2021-01-23 | ECF | 02 | N | GEMCARBO | 100971912 |
| 20115685 | 20134085 | 1.61 | 88.1 | null | 2018-08-08 | 2019-02-25 | CAV | null | N | GEMCITABINE + OXALIPLATIN | 100099316 |
| 20115818 | 20134086 | 1.58 | 47.1 | null | 2019-07-16 | 2019-07-16 | Fluorouracil + Folinic + RT Bossett | 02 | Y | LETROZOLE + PALBOCICLIB | 100922070 |
| 20115859 | 20134087 | 1.71 | 60.5 | Palliative (P) | 2016-06-30 | 2016-07-15 | Trabectedin | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 100803512 |
| 20115948 | 20134088 | 1.57 | 51.7 | Palliative (P) | 2019-12-18 | 2019-12-19 | CISPLATIN + FLUOROURACIL + Trastuzumab | 02 | null | FOXFIRE TRIAL | 100827281 |
| 20115951 | 20134089 | 1.65 | 84 | Curative (C) | 2017-03-31 | 2017-04-13 | Venetoclax | 02 | N | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 100828512 |
| 20116147 | 20134090 | 1.72 | 97.8 | null | 2019-03-18 | 2019-03-24 | COSMIC TRIAL | 02 | null | IRINOTECAN + PANITUMUMAB + RALTITREXED | 101871114 |
| 20116391 | 20134091 | 1.72 | null | Curative (C) | 2018-09-14 | 2018-10-17 | Hepatoblastoma Relapse VI | null | null | RITUXIMAB + VENETOCLAX | 101695215 |
| 20116757 | 20134092 | 1.83 | 112.4 | Adjuvant (A) | 2020-03-03 | 2020-03-10 | FCR Oral - Cycle 2 onwards | 02 | N | CAPECITABINE + STREPTOZOCIN | 100521669 |
| 20116761 | 20134093 | 1.75 | 67.4 | Palliative (P) | null | 2020-10-20 | Hydroxycarbamide | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 100335788 |
| 20116780 | 20134094 | 1.77 | 64 | null | 2018-09-16 | 2018-09-23 | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | 02 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101398674 |
| 20116842 | 20134095 | null | null | Curative (C) | 2017-02-18 | 2017-06-02 | CARBOPLATIN + FLUOROURACIL + Trastuzumab | 02 | N | GO2 TRIAL | 101536116 |
| 20117027 | 20134096 | 1.65 | null | Palliative (P) | 2018-01-18 | 2018-02-08 | TOPOTECAN | 02 | null | ATEZOLIZUMAB | 101790858 |
| 20117132 | 20134097 | 0 | 98.15 | Neo-adjuvant (N) | 2017-11-07 | 2017-11-18 | MITOMYCIN | 02 | N | CAM-PLEX TRIAL | 101176873 |
| 20117565 | 20134099 | 0 | 0 | null | 2018-02-01 | 2018-02-11 | Capecitabine+Cisplatin+Streptozocin | 02 | N | MELPHALAN | 100260787 |
| 20117611 | 20134100 | 1.57 | 65 | 03 | 2019-02-22 | 2019-02-27 | Atezolizumab | 02 | Y | AML17 TRIAL | 101616622 |
| 20117638 | 20134101 | 1.8 | 90.7 | Palliative (P) | 2020-01-15 | 2020-01-21 | Atezolizumab | 02 | N | BEVACIZUMAB + FLUOROURACIL + OXALIPLATIN | 100909407 |
| 20117727 | 20134102 | 1.79 | 22.8 | Palliative (P) | 2020-10-06 | 2020-11-12 | GO2 TRIAL | 01 | null | BACILLUS CALMETTE-GUERIN | 100676526 |
| 20117837 | 20134104 | 1.82 | 63 | null | 2018-08-11 | 2018-09-07 | Hydroxycarbamide | 02 | null | GEMCITABINE + OXALIPLATIN | 100282376 |
| 20117981 | 20134105 | 1.51 | 77 | Curative (C) | 2019-01-23 | 2019-01-24 | Hydroxycarbamide | 02 | N | CEMIPLIMAB | 101145410 |
| 20118474 | 20134106 | 1.81 | 108.3 | null | 2020-05-07 | 2020-06-04 | IBRUTINIB | null | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101224940 |
| 20118537 | 20134107 | 1.84 | 93 | Adjuvant (A) | 2019-03-09 | 2019-03-14 | Carboplatin + Pemetrexed | 02 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101870308 |
| 20118600 | 20134108 | 1.65 | null | null | 2015-11-24 | 2015-12-20 | Olaparib | 02 | N | CAPECITABINE + LOMUSTINE | 101652537 |
| 20118677 | 20134109 | 1.83 | 115.9 | Disease modification (D) | 2019-11-22 | 2019-12-02 | PHITT D SIOPEL-4 (A1, A2, A3) | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100902322 |
| 20118788 | 20134110 | 1.66 | 65 | Curative (C) | 2019-05-04 | 2019-06-03 | Bortezomib + MELPHALAN | 02 | N | CYCLO + DOXORUBICIN + VINCRISTINE | 100730227 |
| 20118980 | 20134111 | 1.82 | 78.5 | Palliative (P) | null | 2020-01-15 | PERTUZUMAB + TRASTUZUMAB | null | N | COSMIC TRIAL | 100678225 |
| 20119084 | 20134112 | 1.64 | 57 | Palliative (P) | 2018-09-21 | 2018-10-05 | RAMUCIRUMAB | 02 | null | FCARBOST | 100909922 |
| 20119241 | 20134113 | 1.68 | 55.2 | Curative (C) | 2019-07-29 | 2019-08-05 | CHOP R - 21 days | 02 | N | PALBOCICLIB | 101277860 |
| 20119269 | 20134115 | 1.69 | 56 | Palliative (P) | 2017-12-27 | 2018-02-20 | PHITT F GEMOX / sorafenib | 02 | N | CAP + RT | 100672395 |
| 20119273 | 20134116 | 1.72 | 83.8 | Palliative (P) | 2020-05-10 | 2020-05-10 | BRIGATINIB | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100337948 |
| 20119473 | 20134117 | 1.89 | 67 | 03 | 2018-12-31 | 2019-05-19 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | TOPOTECAN | 100260275 |
| 20119558 | 20134118 | 1.83 | 58.4 | Curative (C) | 2018-08-05 | 2018-08-05 | Doxorubicin + Olaratumab | N | N | SCOPE2 TRIAL | 100829071 |
| 20119692 | 20134119 | 1.56 | 61.4 | null | 2017-07-26 | 2017-08-05 | BORTEZOMIB + RITUXIMAB | 02 | null | GEMCARBO | 100998086 |
| 20119819 | 20134120 | 1.65 | 53.6 | Palliative (P) | 2018-06-08 | 2018-06-08 | Olaratumab | 02 | N | ECF | 100531834 |
| 20119905 | 20134121 | 1.72 | 62.7 | null | 2018-06-20 | 2018-07-29 | POMALIDOMIDE | 02 | N | GEMCITABINE + PACLITAXEL | 101806113 |
| 20119929 | 20134123 | 1.8 | 74.1 | Palliative (P) | 2021-03-21 | 2021-04-04 | Topotecan (intravenous) | 02 | null | CARBOPLATIN + DOCETAXEL | 101496590 |